Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1988 1
1989 3
1990 5
1991 1
1993 2
1994 6
1995 4
1996 4
1997 4
1998 2
1999 7
2000 11
2001 9
2002 9
2003 9
2004 11
2005 12
2006 10
2007 12
2008 15
2009 7
2010 11
2011 17
2012 18
2013 19
2014 14
2015 20
2016 16
2017 18
2018 14
2019 9
2020 9
2021 9
2022 8
2023 10
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

319 results

Results by year

Filters applied: . Clear all
Page 1
The Genetics of Pneumothorax.
Boone PM, Scott RM, Marciniak SJ, Henske EP, Raby BA. Boone PM, et al. Am J Respir Crit Care Med. 2019 Jun 1;199(11):1344-1357. doi: 10.1164/rccm.201807-1212CI. Am J Respir Crit Care Med. 2019. PMID: 30681372 Free PMC article. Review.
We summarize the pneumothorax-associated genetic syndromes, including Birt-Hogg-Dube syndrome, Marfan syndrome, vascular (type IV) Ehlers-Danlos syndrome, alpha-1 antitrypsin deficiency, tuberous sclerosis complex/lymphangioleiomyomatosis, Loeys-Dietz syndrome, cystic fibr …
We summarize the pneumothorax-associated genetic syndromes, including Birt-Hogg-Dube syndrome, Marfan syndrome, vascular (type IV) Ehlers-Da …
Lymphangioleiomyomatosis: pathogenesis, clinical features, diagnosis, and management.
McCarthy C, Gupta N, Johnson SR, Yu JJ, McCormack FX. McCarthy C, et al. Lancet Respir Med. 2021 Nov;9(11):1313-1327. doi: 10.1016/S2213-2600(21)00228-9. Epub 2021 Aug 27. Lancet Respir Med. 2021. PMID: 34461049 Review.
Lymphangioleiomyomatosis (LAM) is a slowly progressive, low-grade, metastasising neoplasm of women, characterised by infiltration of the lung parenchyma with abnormal smooth muscle-like cells, resulting in cystic lung destruction. ...
Lymphangioleiomyomatosis (LAM) is a slowly progressive, low-grade, metastasising neoplasm of women, characterised by infiltration of …
Tuberous sclerosis complex.
Henske EP, Jóźwiak S, Kingswood JC, Sampson JR, Thiele EA. Henske EP, et al. Nat Rev Dis Primers. 2016 May 26;2:16035. doi: 10.1038/nrdp.2016.35. Nat Rev Dis Primers. 2016. PMID: 27226234 Review.
Remarkable progress in basic and translational research, in addition to several randomized controlled trials worldwide, has led to regulatory approval of the use of mTOR inhibitors for the treatment of renal angiomyolipomas, brain subependymal giant cell astrocytomas and pulmonar …
Remarkable progress in basic and translational research, in addition to several randomized controlled trials worldwide, has led to regulator …
Tuberous sclerosis: a review of the past, present, and future.
Uysal SP, Şahin M. Uysal SP, et al. Turk J Med Sci. 2020 Nov 3;50(SI-2):1665-1676. doi: 10.3906/sag-2002-133. Turk J Med Sci. 2020. PMID: 32222129 Free PMC article. Review.
Subependymal giant cell astrocytomas, renal angiomyolipomas, and epilepsy are the three FDA-approved indications in relation to TSC for the use of everolimus, which is a first generation mTOR inhibitor. Rapamycin has been FDA approved for lymphangioleiomyomatosis. Other TS …
Subependymal giant cell astrocytomas, renal angiomyolipomas, and epilepsy are the three FDA-approved indications in relation to TSC for the …
A Stepwise Diagnostic Approach to Cystic Lung Diseases for Radiologists.
Lee KC, Kang EY, Yong HS, Kim C, Lee KY, Hwang SH, Oh YW. Lee KC, et al. Korean J Radiol. 2019 Sep;20(9):1368-1380. doi: 10.3348/kjr.2019.0057. Korean J Radiol. 2019. PMID: 31464115 Free PMC article. Review.
Multiple/diffuse cysts without associated findings include lymphangioleiomyomatosis and Birt-Hogg-Dube syndrome. Multiple/diffuse cysts may be associated with ground-glass opacity or small nodules. ...
Multiple/diffuse cysts without associated findings include lymphangioleiomyomatosis and Birt-Hogg-Dube syndrome. Multiple/diffuse cys …
Lymphangioleiomyomatosis.
Xu KF, Xu W, Liu S, Yu J, Tian X, Yang Y, Wang ST, Zhang W, Feng R, Zhang T. Xu KF, et al. Semin Respir Crit Care Med. 2020 Apr;41(2):256-268. doi: 10.1055/s-0040-1702195. Epub 2020 Apr 12. Semin Respir Crit Care Med. 2020. PMID: 32279296 Review.
Lymphangioleiomyomatosis (LAM) is a slow albeit progressive rare neoplastic disease featured with diffuse thin-walled cysts in lungs and angiomyolipomas in kidneys. ...
Lymphangioleiomyomatosis (LAM) is a slow albeit progressive rare neoplastic disease featured with diffuse thin-walled cysts in lungs …
Chylothorax and Pseudochylothorax.
Braun CM, Ryu JH. Braun CM, et al. Clin Chest Med. 2021 Dec;42(4):667-675. doi: 10.1016/j.ccm.2021.08.003. Clin Chest Med. 2021. PMID: 34774173 Review.
Lymphangioleiomyomatosis: a metastatic lung disease.
Kundu N, Holz MK. Kundu N, et al. Am J Physiol Cell Physiol. 2023 Feb 1;324(2):C320-C326. doi: 10.1152/ajpcell.00202.2022. Epub 2022 Dec 26. Am J Physiol Cell Physiol. 2023. PMID: 36571446 Free PMC article. Review.
Lymphangioleiomyomatosis (LAM) is a rare disease affecting women, caused by somatic mutations in the TSC1 or TSC2 genes, and driven by estrogen. ...
Lymphangioleiomyomatosis (LAM) is a rare disease affecting women, caused by somatic mutations in the TSC1 or TSC2 genes, and driven b …
Lymphangioleiomyomatosis and Other Cystic Lung Diseases.
Koslow M, Lynch DA, Cool CD, Groshong SD, Downey GP. Koslow M, et al. Immunol Allergy Clin North Am. 2023 May;43(2):359-377. doi: 10.1016/j.iac.2023.01.003. Immunol Allergy Clin North Am. 2023. PMID: 37055093 Free PMC article. Review.
Orphan Lung Diseases.
Ali MS, Ghori UK, Musani AI. Ali MS, et al. Med Clin North Am. 2019 May;103(3):503-515. doi: 10.1016/j.mcna.2018.12.009. Med Clin North Am. 2019. PMID: 30955517 Review.
We have highlighted five of them, one from each of the five major categories of pulmonary disorders: pleuroparenchymal fibroelastosis (a rare diffuse parenchymal lung disease), pulmonary alveolar proteinosis (a rare autoimmune and diffuse parenchymal lung disease), lymphangiol …
We have highlighted five of them, one from each of the five major categories of pulmonary disorders: pleuroparenchymal fibroelastosis (a rar …
319 results